John I Risinger - JoVE Visualize

Showing results (11-20 of 47) with videos related to

Pageof 5

Sort By:

BMC Cancer|May 31, 2018

MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKTJung-Yoon Yoo, Hee-Bum Kang, Russell R Broaddus, et al.

Journal of Drug Targeting|February 1, 2022

Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancerHong Im Kim, Chad R Schultz, Gadisetti V R Chandramouli, et al.

Plos One|June 21, 2013

Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35)Barbara J Davis, John I Risinger, Gadisetti V R Chandramouli, et al.

American Journal of Obstetrics and Gynecology|September 2, 2014

MicroRNAs in endometrial cancers from black and white patientsG Larry Maxwell, Yutaka Shoji, Kathleen Darcy, et al.

Gynecologic Oncology|June 22, 2007

Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomasJay E Allard, John I Risinger, Carl Morrison, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancerG Larry Maxwell, G V R Chandramouli, Lou Dainty, et al.

Cancer Research|January 17, 2009

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic responseOlga Aprelikova, Silvia Pandolfi, Sean Tackett, et al.

Cancer Research|June 17, 2005

Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signalingJohn I Risinger, G Larry Maxwell, Gadisetti V R Chandramouli, et al.

Cancer Research|January 9, 2003

Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancerJohn I Risinger, G Larry Maxwell, G V R Chandramouli, et al.

Molecular Cancer Therapeutics|June 15, 2018

Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the DiseaseAnanda Mukherjee, Amanda L Patterson, Jitu W George, et al.

Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:

Pageof 5

BMC Cancer|May 31, 2018

MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKTJung-Yoon Yoo, Hee-Bum Kang, Russell R Broaddus, et al.

Journal of Drug Targeting|February 1, 2022

Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancerHong Im Kim, Chad R Schultz, Gadisetti V R Chandramouli, et al.

Plos One|June 21, 2013

Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35)Barbara J Davis, John I Risinger, Gadisetti V R Chandramouli, et al.

American Journal of Obstetrics and Gynecology|September 2, 2014

MicroRNAs in endometrial cancers from black and white patientsG Larry Maxwell, Yutaka Shoji, Kathleen Darcy, et al.

Gynecologic Oncology|June 22, 2007

Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomasJay E Allard, John I Risinger, Carl Morrison, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancerG Larry Maxwell, G V R Chandramouli, Lou Dainty, et al.

Cancer Research|January 17, 2009

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic responseOlga Aprelikova, Silvia Pandolfi, Sean Tackett, et al.

Cancer Research|June 17, 2005

Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signalingJohn I Risinger, G Larry Maxwell, Gadisetti V R Chandramouli, et al.

Cancer Research|January 9, 2003

Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancerJohn I Risinger, G Larry Maxwell, G V R Chandramouli, et al.

Molecular Cancer Therapeutics|June 15, 2018

Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the DiseaseAnanda Mukherjee, Amanda L Patterson, Jitu W George, et al.

Pageof 5